The Recall Desk

FDA (Drugs) recall action 79606

Elroselabs Inc. recalled 3 products on 2018-04-18

The FDA (Drugs) publishes a recall like this one as 3 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 3 pages.

Products
3
Announced
2018-04-18
Critical
0
Units
—

Why these products were recalled

cGMP Deviations

The agency’s own wording, quoted from the enforcement report.

1–3 of 3

  • ModerateFDA (Drugs)··2018-04-18

    Elroselabs Recalls Conzerol Topical Cream Due to Manufacturing Deviations

    Elroselabs Inc. is voluntarily recalling Conzerol topical cream nationwide due to cGMP deviations. The recall was initiated in March 2018 and terminated in December 2020.

    Product
    Conzerol zero molluscum contagiosum, Topical Cream, Net weight 0.78 (22g), Elrose Labs, Sanford Fl 32771 USA --- NDC 70223-001-06
    Category
    Distribution
    0 states
  • ModerateFDA (Drugs)··2018-04-18

    Elroselabs Recalls Conzerol Hydrogen Peroxide Gel Due to cGMP Deviations

    Elroselabs Inc. is voluntarily recalling Conzerol Hydrogen Peroxide Gel 3% nationwide due to current Good Manufacturing Practice (cGMP) deviations.

    Product
    Conzerol (antipoxin) H2O2 Gel, Hydrogen Peroxide Gel 3%, 1.5 oz. tube, OTC, Manufactured for Elrose Labs, Inc., Sanford, FL
    Category
    Distribution
    0 states
  • ModerateFDA (Drugs)··2018-04-18

    Elroselabs Recalls Molleave OTC Product Due to cGMP Deviations

    Elroselabs Inc. is voluntarily recalling Molleave, 2 oz bottles, due to current Good Manufacturing Practice (cGMP) deviations. The product was distributed nationwide.

    Product
    Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc.
    Category
    Distribution
    0 states